US PTO has granted two new patents to BioKier

US PTO has granted BioKier patent 9,301,938 which was issued on April 5, 2016. The present invention relates to a method of treating obesity, diabetes and other metabolic diseases by fixed combination of BioKier’s product with monoamine reuptake inhibitors like...

Two New Patents Announced

US PTO has granted BioKier patent 8,470,885 which published on June 25, 2013 Second BioKier patent issued by US PTO on 3/25/14; Patent Number: 8,680,085 Third BioKier patent issued by US PTO on 4/14/15; Patent Number:...

BioKier Takes a Shot at a New Kind of Diabetes Drug

BioKier Takes a Shot at a New Kind of Diabetes Drug Diabetics know all too well that needle sticks are a routine part of managing their disease. Insulin injections have been part of the diabetes standard of care for decades. And in recent years, a new class of...